Cholesterol lowering with bile salt hydrolase-active probiotic bacteria, mechanism of action, clinical evidence, and future direction for heart health applications

Bibliography

• Tarride JE, Lim M, DesMeules M, A review of the cost of cardiovascular disease. Can J Cardiol 2009;25:e195-202
   PubMed Web of Science ®Google Scholar
• Public Health Agency of Canada. Tracking Heart Disease and Stroke in Canada, 2009
   Google Scholar
• World Health Organization. The top 10 causes of death. Fact Sheet No 310, 2011
   Google Scholar
• Durrington P. Dyslipidaemia. Lancet 2003;362:717-31
   PubMed Web of Science ®Google Scholar
• The lipid research clinics coronary primary prevention trial results. I. reduction in incidence of coronary heart disease. JAMA 1984;20:351-64
   Google Scholar
• Muldoon MF, Manuck SB, Matthews KA. Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials. BMJ 1990;301:309-14
   PubMed Web of Science ®Google Scholar
• Ridker PM. Evaluating novel cardiovascular risk factors: can we better predict heart attacks? Ann Intern Med 1999;130:933-7
   PubMed Web of Science ®Google Scholar
• Jacobson TA. “The lower the better” in hypercholesterolemia therapy: a reliable clinical guideline? Ann Intern Med 2000;133:549-54
   PubMed Web of Science ®Google Scholar
• Hunninghake DB. Therapeutic efficacy of the lipid-lowering armamentarium: the clinical benefits of aggressive lipid-lowering therapy. Am J Med 1998;104:9S-13S
   PubMedGoogle Scholar
• National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Circulation 2002;106:3143-421
   PubMed Web of Science ®Google Scholar
• Grundy SM, Cleeman JI, Merz CNB, Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004;110:227-39
   PubMed Web of Science ®Google Scholar
• Genest J, Frohlich J, Fodor G, McPherson R. Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update. CMAJ 2003;169:921-4
   PubMed Web of Science ®Google Scholar
• Smith SC, Allen J, Blair SN, AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update. Circulation 2006;113:2363-72
   PubMed Web of Science ®Google Scholar
• Ornish D, Brown SE, Billings JH, Can lifestyle changes reverse coronary heart disease? Lancet 1990;336:129-33
   PubMed Web of Science ®Google Scholar
• Brautbar A, Ballantyne CM. Pharmacological strategies for lowering LDL cholesterol: statins and beyond. Nat Rev Cardiol 2011;8:253-65
   PubMed Web of Science ®Google Scholar
• Andrews TC, Ballantyne CM, Hsia JA, Kramer JH. Achieving and maintaining national cholesterol education program low-density lipoprotein cholesterol goals with five statins. Am J Med 2001;111:185-91
   PubMed Web of Science ®Google Scholar
• Foley KA, Simpson J, Crouse JR III, Effectiveness of statin titration on low-density lipoprotein cholesterol goal attainment in patients at high risk of atherogenic events. Am J Cardiol 2003;92:79-81
   PubMed Web of Science ®Google Scholar
• Ford ES, Mokdad AH, Giles WH, Mensah GA. Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults. Circulation 2003;107:2185-9
   PubMed Web of Science ®Google Scholar
• Pearson TA, Laurora I, Chu H, Kafonek S. The lipid treatment assessment project (l-tap): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals. Arch Intern Med 2000;160:459-67
   PubMed Web of Science ®Google Scholar
• Frolkis JP, Zyzanski SJ, Schwartz JM, Suhan PS. Physician noncompliance with the 1993 National Cholesterol Education Program (NCEP-ATPII) guidelines. Circulation 1998;98:851-5
   PubMed Web of Science ®Google Scholar
• Davidson MH, Palmisano J, Wilson H, A multicenter, randomized, double-blind clinical trial comparing the low-density lipoprotein cholesterol-lowering ability of lovastatin 10, 20, and 40 mg/d with fluvastatin 20 and 40 mg/d. Clin Ther 2003;25:2738-53
   PubMed Web of Science ®Google Scholar
• Jones P, Kafonek S, Laurora I, Hunninghake D. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (The CURVES Study). Am J Cardiol 1998;81:582-7
   PubMed Web of Science ®Google Scholar
• Sarwar N, Danesh J, Eiriksdottir G, Triglycerides and the risk of coronary heart disease. Circulation 2007;115:450-8
   PubMed Web of Science ®Google Scholar
• Bennet A, Di Angelantonio E, Erqou S, Lipoprotein(a) levels and risk of future coronary heart disease: large-scale prospective data. Arch Intern Med 2008;168:598-608
   PubMed Web of Science ®Google Scholar
• Insull W. The problem of compliance to cholesterol altering therapy. J Intern Med 1997;241:317-25
   PubMed Web of Science ®Google Scholar
• Jones PH. Statins as the cornerstone of drug therapy for dyslipidemia: monotherapy and combination therapy options. Am Heart J 2004;148:S9-S13
   PubMed Web of Science ®Google Scholar
• Kastelein JJP, Akdim F, Stroes ESG, Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med 2008;358:1431-43
   PubMed Web of Science ®Google Scholar
• Taylor AJ, Villines TC, Stanek EJ, Extended-release niacin or ezetimibe and carotid intima−media thickness. N Engl J Med 2009;361:2113-22
   PubMed Web of Science ®Google Scholar
• Barter PJ, Caulfield M, Eriksson M, Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med 2007;357:2109-22
   PubMed Web of Science ®Google Scholar
• Hofmann AF. Bile acid secretion, bile flow and biliary lipidttsecretion in humans. Hepatology 1990;12:17S-22S
   PubMed Web of Science ®Google Scholar
• Midtvedt T. Microbial bile acid transformation. Am J Clin Nutr 1974;27:1341-7
   PubMed Web of Science ®Google Scholar
• Jonsson G, Midtvedt AC, Norman A, Midtvedt T. Intestinal microbial bile acid transformation in healthy infants. J Pediatr Gastroenterol Nutr 1995;20:394-402
   PubMed Web of Science ®Google Scholar
• Trauner M, Boyer JL. Bile salt transporters: molecular characterization, function, and regulation. Physiol Rev 2003;83:633-71
   PubMed Web of Science ®Google Scholar
• Hofmann AF. Bile acids: the good, the bad, and the ugly. Physiology 1999;14:24-9
   Google Scholar
• Prakash S, Tomaro-Duchesneau C, Saha S, Cantor A. The gut microbiota and human health with an emphasis on the use of microencapsulated bacterial cells. J Biomed Biotechnol 2011;2011:12
   Web of Science ®Google Scholar
• Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. FAO, WHO, Argentina; 2001
   Google Scholar
• Rijkers GT, de Vos WM, Brummer R-J, Health benefits and health claims of probiotics: bridging science and marketing. Br J Nutr 2011;106:1291-6
   PubMed Web of Science ®Google Scholar
• Antibiotics in early infancy could raise obesity risk: study. CTV News Canada. 2012. Available from: http://www.ctvnews.ca/health/antibiotics-in-early-infancy-could-raise-obesity-risk-study-1.923213
   Google Scholar
• Microbes maketh man. The Economist 2012; August 18th
   Google Scholar
• Wallace TC, Guarner F, Madsen K, Human gut microbiota and its relationship to health and disease. Nutr Rev 2011;69:392-403
   PubMed Web of Science ®Google Scholar
• Arumugam M, Raes J, Pelletier E, Enterotypes of the human gut microbiome. Nature 2011;473:174-80
   PubMed Web of Science ®Google Scholar
• Bhathena J, Tomaro-Duchesneau C, Martoni C, Effect of orally administered microencapsulated FA-producing L. fermentum on markers of metabolic syndrome: an in vivo analysis. J Diabetes Metab 2012;S2(009)
   Google Scholar
• Huang JS, Bousvaros A, Lee JW, Efficacy of probiotic use in acute diarrhea in children: a meta-analysis. Dig Dis Sci 2002;47:2625-34
   PubMed Web of Science ®Google Scholar
• Szajewska H, Mrukowicz JZ. Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randomized, double-blind, placebo-controlled trials. J Pediatr Gastroenterol Nutr 2001;33:S17-25
   PubMed Web of Science ®Google Scholar
• Szajewska H, Kotowska M, Mrukowicz JZ, Efficacy of lactobacillus GG in prevention of nosocomial diarrhea in infants. J Pediatr 2001;138:361-5
   PubMed Web of Science ®Google Scholar
• Gill HS, Guarner F. Probiotics and human health: a clinical perspective. Postgrad Med J 2004;80:516-26
   PubMed Web of Science ®Google Scholar
• Rayes N, Seehofer D, Hansen S, Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation 2002;74:123-7
   PubMed Web of Science ®Google Scholar
• Saha S, Tomaro-Duchesneau C, Tabrizian M, Prakash S. Probiotics as oral health biotherapeutics. Expert Opin Biol Ther 2012;12:1207-20
   PubMed Web of Science ®Google Scholar
• Lodinova-Zadnikova R, Sonnenborn U. Effect of preventive administration of a nonpathogenic Escherichia coli strain on the colonization of the intestine with microbial pathogens in newborn infants. Neonatology 1997;71:224-32
   Google Scholar
• Hedin CRH, Mullard M, Sharratt E, Probiotic and prebiotic use in patients with inflammatory bowel disease: a case-control study. Inflamm Bowel Dis 2010;16:2099-108
   PubMed Web of Science ®Google Scholar
• Agerbaek M, Gerdes LU, Richelsen B. Hypocholesterolaemic effect of a new fermented milk product in healthy middle-aged men. Eur J Clin Nutr 1995;49:346-52
   PubMed Web of Science ®Google Scholar
• Agerholm-Larsen L, Raben A, Haulrik N, Effect of 8 week intake of probiotic milk products on risk factors for cardiovascular diseases. Eur J Clin Nutr 2000;54:288-97
   PubMed Web of Science ®Google Scholar
• Bertolami MC, Faludi AA, Batlouni M. Evaluation of the effects of a new fermented milk product (Gaio) on primary hypercholesterolemia. Eur J Clin Nutr 1999;53:97-101
   PubMed Web of Science ®Google Scholar
• Ooi LG, Ahmad R, Yuen KH, Liong MT. Lactobacillus acidophilus CHO-220 and inulin reduced plasma total cholesterol and low-density lipoprotein cholesterol via alteration of lipid transporters. J Dairy Sci 2010;93:5048-58
   PubMed Web of Science ®Google Scholar
• Schaafsma G, Meuling WJ, van Dokkum W, Bouley C. Effects of a milk product, fermented by Lactobacillus acidophilus and with fructo-oligosaccharides added, on blood lipids in male volunteers. Eur J Clin Nutr 1998;52:436-40
   PubMed Web of Science ®Google Scholar
• Jones ML, Martoni CJ, Parent M, Prakash S. Cholesterol-lowering efficacy of a microencapsulated bile salt hydrolase-active Lactobacillus reuteri NCIMB 30243 yoghurt formulation in hypercholesterolaemic adults. Br J Nutr 2012;107:1505-13
   PubMed Web of Science ®Google Scholar
• Cani PD. The role of the gut microbiota in energy metabolism and metabolic disease. Curr Pharm Des 2009;15:1546-58
   PubMed Web of Science ®Google Scholar
• Lepage P, Leclerc MC, Joossens M, A metagenomic insight into our gut's microbiome. Gut 2012: in press
   Web of Science ®Google Scholar
• Hord NG. Eukaryotic-microbiota crosstalk: potential mechanisms for health benefits of prebiotics and probiotics. Annu Rev Nutr 2008;28:215-31
   PubMed Web of Science ®Google Scholar
• Coates ME, Ford JE, Harrison GF. Intestinal synthesis of vitamins of the B complex in chicks. Br J Nutr 1968;22:493-500
   PubMed Web of Science ®Google Scholar
• Kellogg TF, Wostmann BS. The response of germfree rats to dietary cholesterol. Adv Exp Med Biol 1969;3:293
   Google Scholar
• Wostmann BS, Wiech NL, Kung E. Catabolism and elimination of cholesterol in germfree rats. J Lipid Res 1966;7:77-82
   PubMed Web of Science ®Google Scholar
• Madsen D, Beaver M, Chang L, Analysis of bile acids in conventional and germfree rats. J Lipid Res 1976;17:107-11
   PubMed Web of Science ®Google Scholar
• Jones BV, Begley M, Hill C, Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome. Proc Natl Acad Sci USA 2008;105:13580-5
   PubMed Web of Science ®Google Scholar
• Kellogg TF, Wostmann BS. Fecal neutral steroids and bile acids from germfree rats. J Lipid Res 1969;10:495-503
   PubMed Web of Science ®Google Scholar
• Kellogg TF, Knight PL, Wostmann BS. Effect of bile acid deconjugation on the fecal excretion of steroids. J Lipid Res 1970;11:362-6
   PubMed Web of Science ®Google Scholar
• Wostmann BS. Intestinal bile acids and cholesterol absorption in the germfree rat. J Nutr 1973;103:982-90
   PubMed Web of Science ®Google Scholar
• Lepercq P, Relano P, Cayuela C, Juste C. Bifidobacterium animalis strain DN-173 010 hydrolyses bile salts in the gastrointestinal tract of pigs. Scand J Gastroenterol 2004;39:1266-71
   PubMed Web of Science ®Google Scholar
• De Smet I, De Boever P, Verstraete W. Cholesterol lowering in pigs through enhanced bacterial bile salt hydrolase activity. Br J Nutr 1998;79:185-94
   PubMed Web of Science ®Google Scholar
• Bateup JM, McConnell MA, Jenkinson HF, Tannock GW. Comparison of lactobacillus strains with respect to bile salt hydrolase activity, colonization of the gastrointestinal tract, and growth rate of the murine host. Appl Environ Microbiol 1995;61:1147-9
   PubMed Web of Science ®Google Scholar
• Dashkevicz MP, Feighner SD. Development of a differential medium for bile salt hydrolase-active Lactobacillus spp. Appl Environ Microbiol 1989;55:11-16
   PubMed Web of Science ®Google Scholar
• Elkins CA, Savage DC. Identification of genes encoding conjugated bile salt hydrolase and transport in Lactobacillus johnsonii100-100. J Bacteriol 1998;180:4344-9
   PubMed Web of Science ®Google Scholar
• Pereira DIA, McCartney AL, Gibson GR. An in vitro study of the probiotic potential of a bile-salt-hydrolyzing Lactobacillus fermentum strain, and determination of its cholesterol-lowering properties. Appl Environ Microbiol 2003;69:4743-52
   PubMed Web of Science ®Google Scholar
• Grill J-P, Schneider F, Crociani J, Ballongue J. Purification and characterization of conjugated bile salt hydrolase from Bifidobacterium longum BB536. Appl Environ Microbiol 1995;61:2577-82
   PubMed Web of Science ®Google Scholar
• Kim GB, Miyamoto CM, Meighen EA, Lee BH. Cloning and characterization of the bile salt hydrolase genes BSH from Bifidobacterium bifidum strains. Appl Environ Microbiol 2004;70:5603-12
   PubMed Web of Science ®Google Scholar
• Kim GB, Yi SH, Lee BH. Purification and characterization of three different types of bile salt hydrolases from bifidobacterium strains. J Dairy Sci 2004;87:258-66
   PubMed Web of Science ®Google Scholar
• Tanaka H, Hashiba H, Kok J, Mierau I. Bile salt hydrolase of Bifidobacterium longum−biochemical and genetic characterization. Appl Environ Microbiol 2000;66:2502-12
   PubMed Web of Science ®Google Scholar
• Coleman JP, Hudson LL. Cloning and characterization of a conjugated bile acid hydrolase gene from Clostridium perfringens. Appl Environ Microbiol 1995;61:2514-20
   PubMed Web of Science ®Google Scholar
• Franz CM, Specht I, Haberer P, Holzapfel WH. Bile salt hydrolase activity of enterococci isolated from food: screening and quantitative determination. J Food Prot 2001;64(5):725-9
   PubMed Web of Science ®Google Scholar
• Kawamoto K, Horibe I, Uchida K. Purification and characterization of a new hydrolase for conjugated bile acids, chenodeoxycholyltaurine hydrolase, from bacteroides vulgatus. J Biochem 1989;106:1049-53
   PubMed Web of Science ®Google Scholar
• Stellwag EJ, Hylemon PB. Purification and characterization of bile salt hydrolase from Bacteroides fragilis subsp. fragilis. Biochim Biophys Acta 1976;452:165-76
   PubMed Web of Science ®Google Scholar
• Kumar M, Nagpal R, Kumar R, Cholesterol-lowering probiotics as potential biotherapeutics for metabolic diseases. Exp Diabetes Res 2012;2012:14
   Google Scholar
• Miyata M, Takamatsu Y, Kuribayashi H, Yamazoe Y. Administration of ampicillin elevates hepatic primary bile acid synthesis through suppression of ileal fibroblast growth factor 15 expression. J Pharmacol Exp Ther 2009;331:1079-85
   PubMed Web of Science ®Google Scholar
• Kawase M, Hashimoto H, Hosoda M, Effect of administration of fermented milk containing whey protein concentrate to rats and healthy men on serum lipids and blood pressure. J Dairy Sci 2000;83:255-63
   PubMed Web of Science ®Google Scholar
• Andersson H, Bosaeus I, Ellegard L, Effects of low-fat milk and fermented low-fat milk on cholesterol absorption and excretion in ileostomy subjects. Eur J Clin Nutr 1995;49:274-81
   PubMed Web of Science ®Google Scholar
• de Roos NM, Schouten G, Katan MB. Yoghurt enriched with Lactobacillus acidophilus does not lower blood lipids in healthy men and women with normal to borderline high serum cholesterol levels. Eur J Clin Nutr 1999;53:277-80
   PubMed Web of Science ®Google Scholar
• Richelsen B, Kristensen K, Pedersen SB. Long-term (6 months) effect of a new fermented milk product on the level of plasma lipoproteins – a placebo-controled and double blind study. Eur J Clin Nutr 1996;50:811-15
   PubMed Web of Science ®Google Scholar
• Greany KA, Bonorden MJL, Hamilton-Reeves JM, Probiotic capsules do not lower plasma lipids in young women and men. Eur J Clin Nutr 2007;62:232-7
   PubMed Web of Science ®Google Scholar
• Lewis SJ, Burmeister S. A double-blind placebo-controlled study of the effects of Lactobacillus acidophilus on plasma lipids. Eur J Clin Nutr 2005;59:776-80
   PubMed Web of Science ®Google Scholar
• Lin SY, Ayres JW, Winkler W Jr, Sandine WE. Lactobacillus effects on cholesterol: in vitro and in vivo results. J Dairy Sci 1989;72:2885-99
   PubMed Web of Science ®Google Scholar
• Pereira DI, Gibson GR. Effects of consumption of probiotics and prebiotics on serum lipid levels in humans. Crit Rev Biochem Mol Biol 2002;37:259-81
   PubMed Web of Science ®Google Scholar
• Guo Z, Liu XM, Zhang QX, Influence of consumption of probiotics on the plasma lipid profile: a meta-analysis of randomised controlled trials. Nutr Metab Cardiovase Dis 2011;21:844-50
   PubMed Web of Science ®Google Scholar
• Jeun J, Kim S, Cho SY, Hypocholesterolemic effects of Lactobacillus plantarum KCTC3928 by increased bile acid excretion in C57BL/6 mice. Nutrition 2010;26:321-30
   PubMed Web of Science ®Google Scholar
• Taranto MP, Medici M, Perdigon G, Effect of Lactobacillus reuteri on the prevention of hypercholesterolemia in mice. J Dairy Sci 2000;83:401-3
   PubMed Web of Science ®Google Scholar
• Usman Hosono A. Effect of administration of Lactobacillus gasseri on serum lipids and fecal steroids in hypercholesterolemic rats. J Dairy Sci 2000;83:1705-11
   PubMed Web of Science ®Google Scholar
• Begley M, Hill C, Gahan CGM. Bile salt hydrolase activity in probiotics. Appl Environ Microbiol 2006;72:1729-38
   PubMed Web of Science ®Google Scholar
• Branton WB, Jones ML, Tomaro-Duchesneau C, In vitro characterization and safety of the probiotic strain Lactobacillus reuteri Cardioviva NCIMB 30242. Int J Probiotics and Prebiotics 2011;6:1-12
   Google Scholar
• Jones ML, Martoni C, Prakash S. Cholesterol lowering and inhibition of sterol absorption by Lactobacillus reuteri NCIMB 30242: a randomized controlled trial. Eur J Clin Nutr 2012;66(11):1234-41
   PubMed Web of Science ®Google Scholar
• Jones ML, Martoni CJ, Di Pietro E, Evaluation of clinical safety and tolerance of a Lactobacillus reuteri NCIMB 30242 supplement capsule: a randomized control trial. Regul Toxicol Pharmacol 2012;63:313-20
   PubMed Web of Science ®Google Scholar
• Jones ML, Martoni CJ, Tamber S, Evaluation of safety and tolerance of microencapsulated Lactobacillus reuteri NCIMB 30242 in a yogurt formulation: a randomized, placebo-controlled, double-blind study. Food Chem Toxicol 2012;50:2216-23
   PubMed Web of Science ®Google Scholar
• Thomas C, Pellicciari R, Pruzanski M, Targeting bile-acid signalling for metabolic diseases. Nat Rev Drug Discov 2008;7:678-93
   PubMed Web of Science ®Google Scholar
• Porez G, Prawitt J, Gross B, Staels B. Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease. J Lipid Res 2012;53:1723-37
   PubMed Web of Science ®Google Scholar
• Yoon H, Ju Jh, Kim H, Lactobacillus rhamnosus BFE 5264 and Lactobacillus plantarum NR74 promote cholesterol excretion through the up-regulation of ABCG5/8 in caco-2 cells. Probiotics Antimicrobial Proteins 2011;3:194-203
   PubMed Web of Science ®Google Scholar
• Yu L, Li-Hawkins J, Hammer RE, Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol. J Clin Invest 2002;110:671-80
   PubMed Web of Science ®Google Scholar
• Johnson BJH, Lee JY, Pickert A, Urbatsch IL. Bile acids stimulate ATP hydrolysis in the purified cholesterol transporter ABCG5/G8. Biochemistry 2010;49:3403-11
   Google Scholar
• Huang Y, Zheng Y. The probiotic Lactobacillus acidophilus reduces cholesterol absorption through the down-regulation of Niemann-Pick C1-like 1 in Caco-2 cells. Br J Nutr 2010;103:478
   Google Scholar
• Sudhop T, Lutjohann D, Kodal A, Inhibition of intestinal cholesterol absorption by ezetimibe in humans. Circulation 2002;106:1943-8
   PubMed Web of Science ®Google Scholar
• Altmann SW, Davis HR, Zhu LJ, Niemann-pick C1 like 1 protein is critical for intestinal cholesterol absorption. Science 2004;303:1201-4
   PubMed Web of Science ®Google Scholar
• Huang Y, Wang J, Cheng Y, Zheng Y. The hypocholesterolaemic effects of Lactobacillus acidophilus American type culture collection 4356 in rats are mediated by the down-regulation of Niemann-Pick C1-like 1. Br J Nutr 2010;104:807-12
   PubMed Web of Science ®Google Scholar
• Liong MT, Shah NP. Bile salt deconjugation ability, bile salt hydrolase activity and cholesterol co-precipitation ability of Lactobacilli strains. Int Dairy J 2005;15:391-8
   Web of Science ®Google Scholar
• Yoon Hs, Ju Jh, Kim HN, Reduction in cholesterol absorption in Caco-2 cells through the down-regulation of Niemann-Pick C1-like 1 by the putative probiotic strains Lactobacillus rhamnosus BFE5264 and Lactobacillus plantarum NR74 from fermented foods. Int J Food Sci Nutr 2012; [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Yoon Hs, Ju Jh, Kim HN, The probiotic lactobacillus rhamnosus BFE5264 and lactobacillus plantarum NR74 promote cholesterol efflux and suppress inflammation in THP-1 cells. J Sci Food Agric 2012; [Epub ahead of print]
   Web of Science ®Google Scholar
• Pischon T, Girman CJ, Sacks FM, Non−high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men. Circulation 2005;112:3375-83
   PubMed Web of Science ®Google Scholar
• Sniderman AD, Zhang Z, Genest J, Cianflone K. Effects on apoB-100 secretion and bile acid synthesis by redirecting cholesterol efflux from HepG2 cells. J Lipid Res 2003;44:527-32
   PubMed Web of Science ®Google Scholar
• Visser ME, Kastelein JJ, Stroes ES. Apolipoprotein B synthesis inhibition: results from clinical trials. Curr Opin Lipidol 2010;21:319-23
   PubMed Web of Science ®Google Scholar
• Jones ML, Martoni CJ, Prakash S. Letter to the editor regarding the report of Duboc et al: connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel disease. Gut 2012; In press
   Web of Science ®Google Scholar
• Danielsson H, Gustafsson B. On serum-cholesterol levels and neutral fecal sterols in germ-free rats. Bile acids and steroids 59. Arch Biochem Biophys 1959;83:482-5
   PubMed Web of Science ®Google Scholar
• Miettinen TA, Gylling H. Regulation of cholesterol metabolism by dietary plant sterols. Curr Opin Lipidol 1999;10:9-14
   PubMed Web of Science ®Google Scholar
• Miettinen TA, Railo M, Lepantalo M, Gylling H. Plant sterols in serum and in atherosclerotic plaques of patients undergoing carotid endarterectomy. J Am Coll Cardiol 2005;45:1794-801
   PubMed Web of Science ®Google Scholar
• Kelly ER, Plat J, Mensink RP, Berendschot TT. Effects of long term plant sterol and -stanol consumption on the retinal vasculature: a randomized controlled trial in statin users. Atherosclerosis 2011;214:225-30
   PubMed Web of Science ®Google Scholar
• AbuMweis SS, Barake R, Jones PJH. Plant sterols/stanols as cholesterol lowering agents: a meta-analysis of randomized controlled trials. Food Nutr Res 2008;52:17
   Google Scholar
• Ortega RM, Palencia A, Lopez-Sobaler AM. Improvement of cholesterol levels and reduction of cardiovascular risk via the consumption of phytosterols. Br J Nutr 2006;96:S89-93
   PubMed Web of Science ®Google Scholar
• Talati R, Sobieraj DM, Makanji SS, The comparative efficacy of plant sterols and stanols on serum lipids: a systematic review and meta-analysis. J Am Diet Assoc 2010;110:719-26
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration. Food labeling; health claim; phytosterols and risk of coronary heart disease proposed rules. Federal Register, Rockville, Maryland; 2010. p. 75
   Google Scholar
• EFSA Panel on Dietetic Products NaA. Scientific opinion on the substantiation of a health claim related to 3 g/day plant sterols/stanols and lowering blood LDL-cholesterol and reduced risk of (coronary) heart disease pursuant to Article 19 of Regulation (EC) No 1924/2006. EFSA J 2012;10:2693
   Google Scholar
• Othman RA, Moghadasian MH, Jones PJ. Cholesterol-lowering effects of oat B-glucan. Nutr Rev 2011;69:299-309
   PubMed Web of Science ®Google Scholar
• Tiwari U, Cummins E. Meta-analysis of the effect of B-glucan intake on blood cholesterol and glucose levels. Nutrition 2011;27:1008-16
   PubMed Web of Science ®Google Scholar
• EFSA Panel on Dietetic Products NaA. Scientific opinion on the substantiation of a health claim related to oat beta-glucan and lowering cholesterol and reduced risk of (coronary) heart disease pusuant to Article 14 of regulation (EC) No 1924/2006. EFSA J 2010;8:1885-900
   Google Scholar
• EFSA Panel on Dietetic Products NaA. Scientific opinion on the substantiation of a health claim related to barley beta-glucan and lowering cholesterol and reduced risk of (coronary) heart disease pursuant to Article 14 of regulation (EC) No 1924/2006. EFSA J 2011;9:2471-87
   Google Scholar
• Wei Z, Wang H, Chen X, Time- and dose-dependent effect of psyllium on serum lipids in mild-to-moderate hypercholesterolemia: a meta-analysis of controlled clinical trials. Eur J Clin Nutr 2008;63:821-7
   PubMed Web of Science ®Google Scholar
• Anderson JW, Allgood LD, Lawrence A, Cholesterol-lowering effects of psyllium intake adjunctive to diet therapy in men and women with hypercholesterolemia: meta-analysis of 8 controlled trials. Am J Clin Nutr2000;71:472-9
   PubMed Web of Science ®Google Scholar
• McVeigh BL, Dillingham BL, Lampe JW, Duncan AM. Effect of soy protein varying in isoflavone content on serum lipids in healthy young men. Am J Clin Nutr 2006;83:244-51
   PubMed Web of Science ®Google Scholar
• Anderson JW, Bush HM. Soy protein effects on serum lipoproteins: a quality assessment and meta-analysis of randomized, controlled studies. J Am Coll Nutr 2011;30:79-91
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration. Food labeling: health claims; soy protein and coronary heart disease. Fed Regist 1999;64:57699-733
   Google Scholar
• Erdman JW for the AHA Nutrition Committee. Soy protein and cardiovascular disease. Circulation 2000;102:2555-9
   PubMed Web of Science ®Google Scholar